Benutzerspezifische Werkzeuge

Publikationen - 2012

Kast,K., Neuhann,T.M., Gorgens,H., Becker,K., Keller,K., Klink,B., Aust,D., Distler,W., Schrock,E., and Schackert,H.K. (2012). Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer. BMC. Cancer 12, 531.
Engel,C., Loeffler,M., Steinke,V., Rahner,N., Holinski-Feder,E., Dietmaier,W., Schackert,H.K., Goergens,H., von Knebel,D.M., Goecke,T.O., Schmiegel,W., Buettner,R., Moeslein,G., Letteboer,T.G., Gomez,G.E., Hes,F.J., Hoogerbrugge,N., Menko,F.H., van Os,T.A., Sijmons,R.H., Wagner,A., Kluijt,I., Propping,P., and Vasen,H.F. (2012). Risks of less common cancers in proven mutation carriers with lynch syndrome. J. Clin. Oncol. 30, 4409-4415.
Plaschke,J., Preussler,M., Ziegler,A., and Schackert,H.K. (2012). Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability. Int. J. Colorectal Dis. 27, 911-919.
Tomsic,J., Liyanarachchi,S., Hampel,H., Morak,M., Thomas,B.C., Raymond,V.M., Chittenden,A., Schackert,H.K., Gruber,S.B., Syngal,S., Viel,A., Holinski-Feder,E., Thibodeau,S.N., and de la,C.A. (2012). An American founder mutation in MLH1. Int. J. Cancer 130, 2088-2095.
Rahner,N., Brockschmidt,F.F., Steinke,V., Kahl,P., Becker,T., Vasen,H.F., Wijnen,J.T., Tops,C.J., Holinski-Feder,E., Ligtenberg,M.J., Spruijt,L., Gorgens,H., Stemmler,S., Kloor,M., Dietmaier,W., Schumacher,J., Nothen,M.M., and Propping,P. (2012). Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors. Fam. Cancer 11, 19-26.